Theis, Hendrik
Prange, Stéphane http://orcid.org/0000-0002-0812-7634
Bischof, Gérard N.
Hoenig, Merle C.
Tittgemeyer, Marc
Timmermann, Lars
Fink, Gereon R. http://orcid.org/0000-0002-8230-1856
Drzezga, Alexander http://orcid.org/0000-0001-6018-716X
Eggers, Carsten
van Eimeren, Thilo http://orcid.org/0000-0002-6951-2325
Article History
Received: 29 April 2023
Accepted: 25 October 2023
First Online: 15 November 2023
Competing interests
: A.D. reports the following competing interests: Research support: Siemens Healthineers, Life Molecular Imaging, GE Healthcare, AVID Radiopharmaceuticals, Sofie, Eisai, Novartis/AAA, Ariceum Therapeutics Speaker Honorary/Advisory Boards: Siemens Healthineers, Sanofi, GE Healthcare, Biogen, Novo Nordisk, Invicro, Novartis/AAA, Bayer Vital Stock: Siemens Healthineers, Lantheus Holding, Structured therapeutics, ImmunoGen Patents: Patent for 18F-JK-PSMA- 7 (2-Alkoxy-6-[18F]Fluoronicotinoyl substituted Lys-C(O)-Glu derivatives as efficient probes for imaging of PSMA expressing tissues (Patent No.: EP3765097A1; Date of patent: Jan. 20, 2021)). The other authors declare no competing interests.